Skip to main content
. 2022 Jan 26;14(3):616. doi: 10.3390/cancers14030616

Figure 2.

Figure 2

Cumulative incidence of count recovery. Count recovery in all patients with ≤5% bone marrow blasts by central ΔN flow cytometry at the end of Induction I who went on to receive Induction II therapy on AAML0531 and AAML1031.